NSI-1

N/A

Report date: 2025/01/26 17:37:41

Base Information

Drug NameNSI-1
Drug Alias Namegadolinium-based MRI contrast agent (Nanosion)NSI-1
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanosion Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanosion Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A